Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-03-20 00:00:00 ET · period of report 2024-03-18 · accession 0001048477-24-000052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-20 | 2024-03-18 | BMRN | Slamon Dennis | Dir | F - Tax | $83.81 | -9,510 | 31.3K | -23% | -$797.0K |
| D | 2024-03-20 | 2024-03-18 | BMRN | Slamon Dennis | Dir | M - OptEx | $79.70 | +10.0K | 40.8K | +32% | +$797.0K |
| D | 2024-03-20 | 2024-03-18 | BMRN | Slamon Dennis | Dir | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-18 | F | D | 9,510 | $83.81 | 31,299 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-18 | M | A | 10,000 | $79.70 | 40,809 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-03-18 | M | D | 10,000 | $0.00 | 0 | D | $79.70 · 2014-07-19 to 2024-03-18 | 10,000 Common Stock | (F1) Reflects the number of options outstanding after the transaction from this specific stock option grant. |